JP2019506897A - ヒトのセレブロンを発現するトランスジェニックマウス - Google Patents

ヒトのセレブロンを発現するトランスジェニックマウス Download PDF

Info

Publication number
JP2019506897A
JP2019506897A JP2018555851A JP2018555851A JP2019506897A JP 2019506897 A JP2019506897 A JP 2019506897A JP 2018555851 A JP2018555851 A JP 2018555851A JP 2018555851 A JP2018555851 A JP 2018555851A JP 2019506897 A JP2019506897 A JP 2019506897A
Authority
JP
Japan
Prior art keywords
compound
crbn
mouse
human crbn
transgenic mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018555851A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506897A5 (enExample
Inventor
チョプラ ラジェシュ
チョプラ ラジェシュ
クリッペル アンケ
クリッペル アンケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of JP2019506897A publication Critical patent/JP2019506897A/ja
Publication of JP2019506897A5 publication Critical patent/JP2019506897A5/ja
Priority to JP2022020184A priority Critical patent/JP7350911B2/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2018555851A 2016-01-19 2017-01-18 ヒトのセレブロンを発現するトランスジェニックマウス Pending JP2019506897A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022020184A JP7350911B2 (ja) 2016-01-19 2022-02-14 ヒトのセレブロンを発現するトランスジェニックマウス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662280633P 2016-01-19 2016-01-19
US62/280,633 2016-01-19
PCT/US2017/013909 WO2017127414A1 (en) 2016-01-19 2017-01-18 Transgenic mouse expressing human cereblon

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022020184A Division JP7350911B2 (ja) 2016-01-19 2022-02-14 ヒトのセレブロンを発現するトランスジェニックマウス

Publications (2)

Publication Number Publication Date
JP2019506897A true JP2019506897A (ja) 2019-03-14
JP2019506897A5 JP2019506897A5 (enExample) 2020-03-05

Family

ID=59362645

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018555851A Pending JP2019506897A (ja) 2016-01-19 2017-01-18 ヒトのセレブロンを発現するトランスジェニックマウス
JP2022020184A Active JP7350911B2 (ja) 2016-01-19 2022-02-14 ヒトのセレブロンを発現するトランスジェニックマウス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022020184A Active JP7350911B2 (ja) 2016-01-19 2022-02-14 ヒトのセレブロンを発現するトランスジェニックマウス

Country Status (4)

Country Link
US (2) US11963520B2 (enExample)
EP (1) EP3405790B1 (enExample)
JP (2) JP2019506897A (enExample)
WO (1) WO2017127414A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
JP7534849B2 (ja) 2017-02-03 2024-08-15 セルジーン コーポレイション セレブロンに対する小分子の親和性の測定方法
EP3861854B1 (en) * 2018-09-27 2025-01-22 Central Institute for Experimental Medicine and Life Science Immunodeficient mouse
JP6935383B2 (ja) * 2018-09-27 2021-09-15 公益財団法人実験動物中央研究所 免疫不全マウス
BR112022008677A2 (pt) 2019-11-05 2022-07-19 Celgene Corp Terapia de combinação com 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidina-3-il)-1-oxoisoindolin-5-il) metil)-2,2-difluoroacetamida
CN112980882A (zh) * 2021-03-15 2021-06-18 上海科技大学 Crbn基因在构建GSPT1敏感模型中的用途
WO2025164957A1 (ko) * 2024-01-31 2025-08-07 남부대학교산학협력단 인간화된 세레브론 넉인 마우스 모델 및 이를 이용한 다발성 골수종 항암화학요법의 효능 평가 방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037757A1 (en) * 1997-02-28 1998-09-03 Kirin Beer Kabushiki Kaisha Pluripotent cells having disrupted intrinsic genes
JP2004533826A (ja) * 2001-04-18 2004-11-11 ジーン ストリーム プロプライエトリー リミティッド 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物
JP2010514421A (ja) * 2006-12-22 2010-05-06 ジェネンテック， インコーポレイテッド ヒト化ｖｅｇｆを発現するトランスジェニックマウス
WO2014123267A1 (ko) * 2013-02-07 2014-08-14 광주과학기술원 Crbn ko 마우스의 제조방법 및 이의 용도
WO2015077058A2 (en) * 2013-11-08 2015-05-28 The Broad Institute, Inc. Compositions and methods for selecting a treatment for b-cell neoplasias

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
US6875904B2 (en) * 2000-09-20 2005-04-05 The Ohio State University Research Foundation Animal model for identifying agents that inhibit or enhance CTLA4 signaling
EP1573314B1 (en) * 2002-12-16 2008-07-23 Genentech, Inc. Transgenic mice expressing human cd20
US20120134969A1 (en) 2009-05-25 2012-05-31 Hiroshi Handa Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
CN103688176A (zh) 2011-04-29 2014-03-26 细胞基因公司 利用cereblon作为预报因子治疗癌和炎性疾病的方法
US9587281B2 (en) * 2012-08-14 2017-03-07 Celgene Corporation Cereblon isoforms and their use as biomarkers for therapeutic treatment
WO2014028445A2 (en) 2012-08-14 2014-02-20 Celgene Corporation Cereblon isoforms and their use as biomarkers for therapeutic treatment
WO2015127351A1 (en) 2014-02-24 2015-08-27 Celgene Corporation Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
JP6640126B2 (ja) 2014-06-27 2020-02-05 セルジーン コーポレイション セレブロン及び他のｅ３ユビキチンリガーゼの立体構造の変化を誘導するための組成物及び方法
JP7534849B2 (ja) 2017-02-03 2024-08-15 セルジーン コーポレイション セレブロンに対する小分子の親和性の測定方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037757A1 (en) * 1997-02-28 1998-09-03 Kirin Beer Kabushiki Kaisha Pluripotent cells having disrupted intrinsic genes
JP2004533826A (ja) * 2001-04-18 2004-11-11 ジーン ストリーム プロプライエトリー リミティッド 薬理学的及び毒性学的研究のための非ヒトトランスジェニック動物
JP2010514421A (ja) * 2006-12-22 2010-05-06 ジェネンテック， インコーポレイテッド ヒト化ｖｅｇｆを発現するトランスジェニックマウス
WO2014123267A1 (ko) * 2013-02-07 2014-08-14 광주과학기술원 Crbn ko 마우스의 제조방법 및 이의 용도
WO2015077058A2 (en) * 2013-11-08 2015-05-28 The Broad Institute, Inc. Compositions and methods for selecting a treatment for b-cell neoplasias

Also Published As

Publication number Publication date
EP3405790A1 (en) 2018-11-28
JP7350911B2 (ja) 2023-09-26
US11963520B2 (en) 2024-04-23
EP3405790A4 (en) 2019-10-02
US20240389562A1 (en) 2024-11-28
US20190037818A1 (en) 2019-02-07
JP2022078072A (ja) 2022-05-24
EP3405790B1 (en) 2023-06-28
WO2017127414A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
JP7350911B2 (ja) ヒトのセレブロンを発現するトランスジェニックマウス
Klover et al. Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden
EP3058819B1 (en) Hla class i expressing non-human animal
US11272695B2 (en) Genetically modified non-human animal with human or chimeric PD-1
US20230172171A1 (en) Genetically modified non-human animal with human or chimeric cd94 and/or nkg2a
JP6282591B2 (ja) 遺伝子ノックイン非ヒト動物
JP2022134132A (ja) ヒトｇｐｃ３ポリペプチドを発現する遺伝子改変非ヒト動物
US8389792B2 (en) Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same
WO2020103830A1 (en) Genetically modified animal with canine or chimeric pd-1
US20230148575A1 (en) Genetically modified non-human animal with human or chimeric il1b and/or il1a
US20230165227A1 (en) Genetically modified non-human animal with human or chimeric cd276
JP2008029319A (ja) 樹状細胞免疫受容体遺伝子ノックアウト疾患モデル動物
JP2019509059A (ja) 変異型キヌレニナーゼ遺伝子を有する非ヒト動物
WO2022258049A1 (en) Genetically modified non-human animal with human or chimeric pvrig
US11564381B2 (en) Genetically modified non-human animal with human or chimeric LAG3
US20060156419A1 (en) Mouse model for autoimmune disorders
WO2006001981A2 (en) Methods for treating disease by modulating an osmotic stress pathway
WO2022012636A1 (en) Genetically modified non-human animal with human or chimeric il17a and/or il17f
JP2005517410A (ja) Ｌａｔタンパク質をコードする突然変異型遺伝子及びその生物学的適用
JP2007054073A (ja) Ｎｋｔ細胞欠損動物及びｎｋｔ細胞動物
HK1223507B (en) A method for preparing a non-human animal expressing hla class i
JP2010276505A (ja) 新規癌転移抑制剤の探索法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200115

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20200115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210409

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210712

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20211026

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220214

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20220301

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220301

C27A Decision to dismiss

Free format text: JAPANESE INTERMEDIATE CODE: C2711

Effective date: 20220419

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220510

C032 Notice prior to dismissal

Free format text: JAPANESE INTERMEDIATE CODE: C032

Effective date: 20220531

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20220531